Astellas taps AI to reshape clinical programs as rising stars emerge

Astellas taps AI to reshape clinical programs as rising stars emerge is a pharma and life sciences industry update from PharmaVoice. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.

Meagan Parrish · 2026-06-12

As it prepares to compete in the KRAS arena, the Japanese pharma has retooled its approach to clinical development.

Source: PharmaVoice